Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
19,430,818
-
Shares change
-
+73,962
-
Total reported value, excl. options
-
$956,710,887
-
Value change
-
+$7,403,943
-
Put/Call ratio
-
2.71%
-
Number of buys
-
65
-
Number of sells
-
-72
-
Price
-
$49.32
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q1 2021
166 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q1 2021.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,430,818 shares
of 27,767,902 outstanding shares and own 69.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,729,571 shares), Farallon Capital Management, L.L.C. (1,995,000 shares), VANGUARD GROUP INC (1,898,674 shares), ARMISTICE CAPITAL, LLC (1,648,000 shares), STATE STREET CORP (1,098,124 shares), RENAISSANCE TECHNOLOGIES LLC (900,200 shares), PRICE T ROWE ASSOCIATES INC /MD/ (864,261 shares), Krensavage Asset Management, LLC (862,848 shares), NORTHERN TRUST CORP (644,914 shares), and DIMENSIONAL FUND ADVISORS LP (587,496 shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.